相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Integrase strand transfer inhibitor-associated diabetes mellitus: A case report
Peter S. Fong et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2017)
Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009-2010
Alfonso C. Hernandez-Romieu et al.
BMJ OPEN DIABETES RESEARCH & CARE (2017)
Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study
Antonella Castagna et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Dolutegravir, the Second-Generation of Integrase Strand Transfer Inhibitors (INSTIs) for the Treatment of HIV
Dorothy E. Dow et al.
INFECTIOUS DISEASES AND THERAPY (2014)
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
Pedro Cahn et al.
LANCET (2013)
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
Francois Raffi et al.
LANCET (2013)
Dolutegravir plus Abacavir-Lamivudine for the Treatment of HIV-1 Infection
Sharon L. Walmsley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)